Health Newsfeed – Johns Hopkins Medicine Podcasts

Pancreas cancer is associated with a very poor prognosis, with many people diagnosed with the disease given only months or a couple of years of predicted life remaining. Now an AI model may discern who is at risk to develop …

An AI model may help predict who is more likely to develop pancreas cancer, Elizabeth Tracey reports Read more →

In trying to discern factors that may account for colorectal cancer incidence in younger people many diet and lifestyle factors fell short, a new study finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, points toward insulin …

Will GLP1 drugs tease out the relationship between insulin and cancer? Elizabeth Tracey reports Read more →

A new, comprehensive study takes a look at lifestyle factors and colorectal cancer in younger people and fails to find a relationship. Kimmel Cancer Center director William Nelson at Johns Hopkins says he thinks it may be more subtle and …

Is there a relationship between diet, obesity and colorectal cancer? Elizabeth Tracey reports Read more →

A comprehensive look at lifestyle factors and cancer rates among both older and younger people has left many people scratching their heads. The UK study examined a range of exposures and lifestyle factors trying to elucidate relationships, especially those that …

What accounts for increases in colorectal cancer among younger people? Elizabeth Tracey reports Read more →

Daraxonrasib is the name of a drug for pancreas cancer that almost doubled survival for people with the disease in a clinical trial. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says while the drug is going …

A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports Read more →

Daraxonrasib is the name of a drug to treat pancreas cancer that has extended survival in many with the disease, a just reported clinical trial finds.  Johns Hopkins Kimmel Cancer Center director William Nelson says it’s gotten many people who treat …

A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports Read more →

New guidelines for managing cholesterol levels have recently been released by the American College of Cardiology. Cardiologist Roger Blumenthal at Johns Hopkins chaired the committee that wrote the guidelines, and says that in reviewing the data it became clear that …

Certain groups of people seem to be missing out when it comes to optimizing cardiovascular disease prevention, Elizabeth Tracey reports Read more →

Cholesterol found in your blood is just the beginning of the story when it comes to markers found there that are indicative of cardiovascular risk. A relative newcomer is apolipoprotein a, which is genetically determined, says Roger Blumenthal, a cardiologist …

What markers are found in blood that indicate cardiovascular risk? Elizabeth Tracey reports Read more →

When it comes to assessing your cardiovascular risk, your blood tells an eloquent story. It’s not just cholesterol but several other factors that can be detected and measured that point toward or away from risk. Roger Blumenthal, a cardiologist at …

What does a blood marker called lipoprotein A have to do with your risk for cardiovascular disease? Elizabeth Tracey reports Read more →

Cholesterol management, per new guidelines from the American College of Cardiology, is just one aspect of measures you can take to lower your risk for cardiovascular disease, the number one cause of death. Roger Blumenthal, a cardiologist at Johns Hopkins …

What’s involved in lowering your risk for cardiovascular disease? Elizabeth Tracey reports Read more →